In ovarian cancer, JADE2 has been shown to be highly overexpressed and may function to regulate YAP1 a critical ovarian cancer oncogene [30], whilst a gene fusion between JADE2 and NUP98 has been observed in a pediatric acute myeloid leukemia [31]. This evidence concerns the gene YAP1 and ovarian cancer.